Clinical Research
Total Trials
26
As Lead Sponsor
1
As Collaborator
25
Total Enrollment
5,573
NCT00966472
Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC
Phase: Phase 1
Role: Collaborator
Start: Mar 31, 2009
Completion: Sep 30, 2014
NCT01310231
A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 22, 2011
Completion: Mar 26, 2018
NCT02215850
Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours
Start: Oct 31, 2014
Completion: Mar 31, 2016
NCT02254785
Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer
Completion: May 31, 2020
NCT02268370
Treatment-free Remission Accomplished With Dasatinib in Patients With CML
Completion: Oct 31, 2021
NCT02483312
A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML)
Start: Sep 30, 2015
Completion: Aug 31, 2025
NCT02569645
Rosuvastatin in the Treatment of Rectal Cancer
Start: Nov 30, 2015
Completion: Sep 24, 2021
NCT02743741
Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors
Phase: N/A
Start: Jul 15, 2016
Completion: Jun 30, 2026
NCT02800070
Autologous Stem Cell Transplantation of Cells Engineered to Express Alpha-Galactosidase A in Patients With Fabry Disease
Start: Jul 31, 2016
Completion: Apr 30, 2024
NCT02599779
A Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC Patients
Start: Dec 31, 2016
Completion: Aug 5, 2021
NCT02750670
Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Start: Mar 15, 2017
Completion: Feb 9, 2021
NCT03192306
Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for Episodic Treatment of Cold Sores
Start: Jul 5, 2017
Completion: Apr 2, 2018
NCT03027102
Study of Allogeneic Double Negative T Cells (DNT-UHN-1) in Patients With High Risk Acute Myeloid Leukemia
Start: Aug 15, 2017
Completion: Dec 10, 2024
NCT03283943
PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.
Start: Apr 1, 2018
Completion: Dec 16, 2020
NCT04698239
Clinical Evaluation of the Safety and Benefits of the Milesman 445 nm Blue Laser on Inflammatory Acne Lesions.
Start: Sep 24, 2020
Completion: Feb 15, 2021
NCT04202835
ATG Plus PTCy vs ATG for CGVHD Prophylaxis
Start: Oct 14, 2020
Completion: Feb 7, 2026
NCT04543110
Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC
Start: Jan 29, 2021
Completion: Nov 30, 2024
NCT04695873
A 3 Day In-use Assessment of the Scholl Corn Foam Cushions on Pain Levels Associated With Heloma Durum.
Start: Jun 16, 2021
Completion: Oct 11, 2021
NCT04944173
SCION: SABR and Checkpoint Inhibition of NSCLC
Start: Aug 11, 2023
Completion: Jun 30, 2027
NCT05848713
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
Phase: Phase 3
Start: Oct 10, 2023
Completion: Mar 31, 2029
NCT06331455
Treatment of Pulmonary SUlcus, Pancoast and Chest Wall Non-small Cell Lung Cancer Employing Radiation, Immuno-oncology and Resection
Start: May 22, 2024
Completion: Apr 30, 2026
NCT06370832
Inspiratory Muscle Training in Lung Transplant Candidates
Start: Aug 6, 2024
Completion: Sep 30, 2027
NCT06222788
Breast Cancer Plasma Adjuvant Intra-operative Treatment (Breast Cancer PAINT)
Start: Sep 30, 2024
Completion: Jan 31, 2026
NCT06650709
NEoadjuvant Olaparib Combination OvArian Cancer Targeted Study
Start: Nov 1, 2024
Completion: Nov 1, 2028
NCT06693336
An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer
Start: Nov 18, 2024
Completion: Oct 30, 2026
NCT06613217
Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia
Start: Mar 3, 2025
Completion: Sep 1, 2026
Loading map...